179 related articles for article (PubMed ID: 29105189)
1. Cyclophosphamide-induced tolerance in kidney transplantation avoids long-term immunosuppressive therapy.
Takeuchi A; Kato K; Akashi K; Eto M
Int J Urol; 2018 Feb; 25(2):112-120. PubMed ID: 29105189
[TBL] [Abstract][Full Text] [Related]
2. Mixed chimerism achieved by a nonlethal conditioning regimen induces donor-specific tolerance to lung allografts.
Li S; Salgar SK; Kurimoto Y; Yousem S; Pham SM
J Surg Res; 2008 May; 146(2):289-97. PubMed ID: 18314139
[TBL] [Abstract][Full Text] [Related]
3. Induction of stable long-term mixed hematopoietic chimerism following nonmyeloablative conditioning with T cell-depleting antibodies, cyclophosphamide, and thymic irradiation leads to donor-specific in vitro and in vivo tolerance.
Mapara MY; Pelot M; Zhao G; Swenson K; Pearson D; Sykes M
Biol Blood Marrow Transplant; 2001; 7(12):646-55. PubMed ID: 11787527
[TBL] [Abstract][Full Text] [Related]
4. CTLA4-Ig-based conditioning regimen to induce tolerance to cardiac allografts.
Li S; Salgar SK; Thanikachalam M; Murdock AD; Gammie JS; Demetris AJ; Zeevi A; Pham SM
J Surg Res; 2006 Dec; 136(2):238-46. PubMed ID: 17046021
[TBL] [Abstract][Full Text] [Related]
5. Depletion of alloreactive T cells for tolerance induction in a recipient of kidney and hematopoietic stem cell transplantations.
Tangnararatchakit K; Tirapanich W; Anurathapan U; Tapaneya-Olarn W; Pakakasama S; Jootar S; Slavin S; Hongeng S
Pediatr Transplant; 2012 Dec; 16(8):E342-7. PubMed ID: 22553996
[TBL] [Abstract][Full Text] [Related]
6. Limited immune tolerance induced by transient mixed chimerism.
Yu JH; Chung BH; Oh EJ; Kim JI; Kim HJ; Moon IS; Yang CW
Korean J Intern Med; 2015 Sep; 30(5):735-8. PubMed ID: 26354070
[No Abstract] [Full Text] [Related]
7. Induction of Major Histocompatibility Complex-mismatched Mouse Lung Allograft Acceptance With Combined Donor Bone Marrow: Lung Transplant Using a 12-Hour Nonmyeloablative Conditioning Regimen.
Dodd-O JM; Ganguly S; Vulic A; Panoskaltsis-Mortari A; McDyer JF; Luznik L
Transplantation; 2016 Dec; 100(12):e140-e146. PubMed ID: 27861294
[TBL] [Abstract][Full Text] [Related]
8. Successful Induction of Specific Immunological Tolerance by Combined Kidney and Hematopoietic Stem Cell Transplantation in HLA-Identical Siblings.
Fehr T; Hübel K; de Rougemont O; Abela I; Gaspert A; Güngör T; Hauri M; Helmchen B; Linsenmeier C; Müller T; Nilsson J; Riesterer O; Scandling JD; Schanz U; Cippà PE
Front Immunol; 2022; 13():796456. PubMed ID: 35173720
[TBL] [Abstract][Full Text] [Related]
9. Requirement of a higher degree of chimerism for skin allograft tolerance in cyclophosphamide-induced tolerance.
Iwai T; Tomita Y; Zhang QW; Shimizu I; Nomoto K; Yasui H
Transpl Int; 2005 May; 17(12):795-803. PubMed ID: 15856178
[TBL] [Abstract][Full Text] [Related]
10. Application of chimerism-based drug-induced tolerance to rat into mouse xenotransplantation.
Tomita Y; Shimizu I; Iwai T; Zhang QW; Okano S; Kajiwara T; Onzuka T; Tominaga R
Scand J Immunol; 2006 Oct; 64(4):392-7. PubMed ID: 16970680
[TBL] [Abstract][Full Text] [Related]
11. Myeloma responses and tolerance following combined kidney and nonmyeloablative marrow transplantation: in vivo and in vitro analyses.
Fudaba Y; Spitzer TR; Shaffer J; Kawai T; Fehr T; Delmonico F; Preffer F; Tolkoff-Rubin N; Dey BR; Saidman SL; Kraus A; Bonnefoix T; McAfee S; Power K; Kattleman K; Colvin RB; Sachs DH; Cosimi AB; Sykes M
Am J Transplant; 2006 Sep; 6(9):2121-33. PubMed ID: 16796719
[TBL] [Abstract][Full Text] [Related]
12. Cyclophosphamide-Induced Tolerance in Allogeneic Transplantation: From Basic Studies to Clinical Application.
Kato K; Takeuchi A; Akashi K; Eto M
Front Immunol; 2019; 10():3138. PubMed ID: 32082305
[TBL] [Abstract][Full Text] [Related]
13. A clinically feasible approach to induce delayed tolerance in recipients of prior kidney or vascularized composite allotransplants.
Chen B; Xu H; Corbin DR; Ildstad ST
Transplantation; 2012 Oct; 94(7):671-8. PubMed ID: 22948444
[TBL] [Abstract][Full Text] [Related]
14. Chimerism and tolerance: past, present and future strategies to prolong renal allograft survival.
Tantisattamo E; Leventhal JR; Mathew JM; Gallon L
Curr Opin Nephrol Hypertens; 2021 Jan; 30(1):63-74. PubMed ID: 33186221
[TBL] [Abstract][Full Text] [Related]
15. Clinical trials for renal allograft tolerance induction through combined hematopoietic stem cell transplantation: A narrative review.
Hotta K; Hirose T; Kawai T
Int J Urol; 2022 Dec; 29(12):1397-1404. PubMed ID: 36101964
[TBL] [Abstract][Full Text] [Related]
16. Tacrolimus-based partial conditioning produces stable mixed lymphohematopoietic chimerism and tolerance for cardiac allografts.
Gammie JS; Li S; Zeevi A; Demetris AJ; Ildstad ST; Pham SM
Circulation; 1998 Nov; 98(19 Suppl):II163-8; discussion II168-9. PubMed ID: 9852899
[TBL] [Abstract][Full Text] [Related]
17. [Organ tolerance and incomplete bone marrow chimera in dogs].
von Scheel J; Kolb HJ; Chaussy C; Rieder I; Duswald KH; Pielsticker K
Chir Forum Exp Klin Forsch; 1977 Apr; ():274-8. PubMed ID: 376244
[TBL] [Abstract][Full Text] [Related]
18. Tolerance induction in clinical transplantation.
Fehr T; Sykes M
Transpl Immunol; 2004; 13(2):117-30. PubMed ID: 15380542
[TBL] [Abstract][Full Text] [Related]
19. Post-transplantation cyclophosphamide for chimerism-based tolerance.
McCurdy SR; Luznik L
Bone Marrow Transplant; 2019 Aug; 54(Suppl 2):769-774. PubMed ID: 31431698
[TBL] [Abstract][Full Text] [Related]
20. A Critical Role for TGF-β/Fc and Nonlytic IL-2/Fc Fusion Proteins in Promoting Chimerism and Donor-Specific Tolerance.
Xu H; Zheng XX; Zhang W; Huang Y; Ildstad ST
Transplantation; 2017 Feb; 101(2):294-301. PubMed ID: 27306533
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
